At a glance
ClinicalIndex Comparison RecordN/ACompleted· 65 enrolled
Drug / intervention
Masimo Rainbow Pulse CO-oximeterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Continuous Non-Invasive Measurement of Hemoglobin During Parturition
The University of Texas Medical Branch, Galveston·interventional·Posted May 11, 2017·Updated Feb 24, 2021
In Brief
A clinical study evaluating Masimo Rainbow Pulse CO-oximeter for Hemorrhage and Cesarean Section. Completed, enrolled 65 participants across 1 site.
Detailed Summary
A non-invasive hemoglobin monitor will be used during cesarean delivery and the values obtained will be compared to values obtained from traditional blood draw.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage, Cesarean Section
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartMay 2017
First PostedMay 2017
Primary CompletionMay 2018
TodayJul 2026
First PostedMay 11, 2017
Enrollment StartMay 10, 2017
Primary CompletionMay 9, 2018
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 9.1 years ago
Interventions
Masimo Rainbow Pulse CO-oximeterdevice
Masimo Rainbow Pulse CO-oximeter will be used to measure hemoglobin values of pregnant women during primary cesarean delivery